Which of the following statements about the Orange Book is true?

The statement that the Orange Book identifies drugs that are bioequivalent is accurate because the Orange Book, officially known as the "Approved Drug Products with Therapeutic Equivalence Evaluations," is published by the FDA. Its primary purpose is to provide healthcare professionals, pharmacists, and other stakeholders with information about generic drugs and their equivalency to brand-name products.

The Orange Book includes a list of approved drug products and designates which of these products are considered therapeutically equivalent—meaning they are expected to have the same clinical effect and safety profile when administered to patients under the conditions specified in the labeling. This bioequivalence is crucial for prescribers and pharmacists when determining suitable alternatives for patients, especially regarding generics, which may be less expensive than their brand-name counterparts.

In other contexts, the other options do not accurately reflect the purpose of the Orange Book: it does not list unsafe drugs, nor does it regulate drug pricing or provide a comprehensive list of all medications stocked in pharmacies. Instead, its focus is specifically on approved products and their therapeutic equivalence.